Barrier or carrier? Pulmonary surfactant and drug delivery.
about
Delivery of RNAi Therapeutics to the Airways-From Bench to BedsideImpact of the New Generation Reconstituted Surfactant CHF5633 on Human CD4+ Lymphocytes.Disulfiram-loaded porous PLGA microparticle for inhibiting the proliferation and migration of non-small-cell lung cancer.Use of cilomilast-loaded phosphatiosomes to suppress neutrophilic inflammation for attenuating acute lung injury: the effect of nanovesicular surface charge.
P2860
Barrier or carrier? Pulmonary surfactant and drug delivery.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Barrier or carrier? Pulmonary surfactant and drug delivery.
@en
type
label
Barrier or carrier? Pulmonary surfactant and drug delivery.
@en
prefLabel
Barrier or carrier? Pulmonary surfactant and drug delivery.
@en
P1476
Barrier or carrier? Pulmonary surfactant and drug delivery.
@en
P2093
Alberto Hidalgo
P304
P356
10.1016/J.EJPB.2015.02.014
P407
P577
2015-02-20T00:00:00Z